trending Market Intelligence /marketintelligence/en/news-insights/trending/Wl-nRJIrZV9EP7sBAZ4o4A2 content esgSubNav
In This List

Ascendis Pharma offering underwriters fully exercise overallotment option

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Ascendis Pharma offering underwriters fully exercise overallotment option

Ascendis Pharma A/S said underwriters of its offering of American depositary shares fully exercised the option to buy 570,000 ADSs.

On Oct. 5 the company closed the sale and issuance of the ADSs pursuant to the underwriting agreement.

The agreement was signed among the company and J.P. Morgan Securities LLC, Merrill Lynch, Pierce Fenner & Smith Inc. and Credit Suisse Securities (USA) LLC as representatives of several underwriters.